Q3 revenues and EBITDA was 7-13% below consensus Cash flow set to improve short term, but still soft in ’22e We would be a seller at the indicated price range
We add Cloudia, change to IFRS and raise LT growth This lifts ’22e revenues by 23% and adj. EBITDA by 18% Strong growth from H2’21, driven by new supplier product
Better organic ARR growth and lower churn in Q1 Financial targets: 15-20% growth + 40% EBITDA margin Capex increase of ~NOK 100m to product development